In yesterday’s Wall Street session, Agilon Health Inc (NYSE:AGL) shares traded at $11.83, up 7.55% from the previous session.
As of this writing, 17 analysts cover Agilon Health Inc (NYSE:AGL). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $30.00 and a low of $12.00, we find $22.50. Given the previous closing price of $11.00, this indicates a potential upside of 104.55 percent. AGL stock price is now -29.46% away from the 50-day moving average and -41.60% away from the 200-day moving average. The market capitalization of the company currently stands at $4.80B.
There are 3 analysts who have given it a hold rating, whereas 14 have given it a buy rating. Brokers who have rated the stock have averaged $21.57 as their price target over the next twelve months.
With the price target reduced from $27 to $12, Deutsche Bank Downgraded its rating from Buy to Hold for Agilon Health Inc (NYSE: AGL).
In other news, Shaker Benjamin, Chief Markets Officer sold 18,750 shares of the company’s stock on Sep 13. The stock was sold for $337,455 at an average price of $18.00. Upon completion of the transaction, the Chief Markets Officer now directly owns 79,543 shares in the company, valued at $0.94 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Sep 12, Chief Markets Officer Shaker Benjamin sold 18,750 shares of the business’s stock. A total of $338,481 was realized by selling the stock at an average price of $18.05. This leaves the insider owning 79,543 shares of the company worth $0.94 million. Insiders disposed of 95,626,275 shares of company stock worth roughly $1.13 billion over the past 1 year. A total of 26.08% of the company’s stock is owned by insiders.
Wednesday morning saw Agilon Health Inc (NYSE: AGL) opened at $11.34. During the past 12 months, Agilon Health Inc has had a low of $10.78 and a high of $29.44. As of last week, the company has a debt-to-equity ratio of 0.06, a current ratio of 1.50, and a quick ratio of 1.50. The fifty day moving average price for AGL is $16.77 and a two-hundred day moving average price translates $20.26 for the stock.
The latest earnings results from Agilon Health Inc (NYSE: AGL) was released for Sep, 2023. According to the Medical Care Facilities Company, earnings per share came in at -$0.08, missing analysts’ expectations of -$0.06 by -0.02. This compares to -$0.07 EPS in the same period last year. The net profit margin was -2.11% and return on equity was -9.05% for AGL. The company reported revenue of $1.22 billion for the quarter, compared to $694.86 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 74.95 percent. For the current quarter, analysts expect AGL to generate $1.06B in revenue.
Agilon Health Inc(AGL) Company Profile
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2022, it served approximately 269,500 medicare advantage members and 89,000 Medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.
